Back to SC US (TTGP), LTD. SC US (TTGP), LTD.

QNCXQNCX
10 quarters

Position history for SC US (TTGP), LTD.SC US (TTGP), LTD.'s holdings in QUINCE THERAPEUTICS INC

No. SC US (TTGP) exited its QNCX (Quince Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 560,594 shares worth $29.7M. SC US (TTGP) first reported QNCX in Q2 2019 and held it in 9 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$44.2M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%$18,332.00
0
2021-Q2
Decreased
560,594
-46.1%
$29.7M0.2%$10,600.00
0
2021-Q1
Unchanged
1M
0.0%
$37.5M0.2%$7,206.00
0
2020-Q4
Unchanged
1M
0.0%
$28.9M0.2%$5,556.00
0
2020-Q3
Unchanged
1M
0.0%
$52M0.5%$10,000.00
0
2020-Q2
Unchanged
1M
0.0%
$48.2M2.8%$9,260.00
0
2020-Q1
Unchanged
1M
0.0%
$47.5M3.6%$9,122.00
0
2019-Q4
Unchanged
1M
0.0%
$58.4M2.5%$11,228.00
0
2019-Q3
Unchanged
1M
0.0%
$25.9M1.2%$4,986.00
0
2019-Q2
New
1M
-
$44.2M3.0%$8,502.00
84

Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used